Literature DB >> 17052483

Cholesterol embolism: still an unrecognized entity with a high mortality rate.

Anna Jucgla1, Francesc Moreso, Cristina Muniesa, Abelardo Moreno, Antonio Vidaller.   

Abstract

BACKGROUND: Cholesterol embolism (CE) is an increasingly common but often underdiagnosed medical problem. The recognition of clinical manifestations of CE is the first step toward a correct diagnosis.
OBJECTIVE: Our aim was to characterize the features of CE and the risk factors for fatal outcome.
METHODS: Clinical records of patients with clinical and histopathologic diagnoses of CE seen from January 1993 through March 2003 were reviewed.
RESULTS: Twenty-six male patients were identified. Mean age was 64 years (range, 48-88 years). All patients had two or more risk factors for atherosclerosis. All but one patient had preexisting symptomatic atherosclerotic disease. At least one precipitating factor was identified in 23 patients (88%). Diagnosis of CE at admission was made in 9 patients only (35%). Cutaneous lesions (88%) and renal failure (73%) were the most common clinical findings. Complications (dialysis, acute pulmonary edema, amputation, or gastrointestinal surgery) were present in 21 patients (81%), and 15 patients died (58%). Previous chronic renal failure was the only variable associated with mortality (relative risk: 4.54, 95% confidence interval 1.26-16.6; P = .02). LIMITATIONS: The results were obtained from patients admitted to a university hospital. This fact may have selected a higher proportion of severe cases.
CONCLUSIONS: CE was frequently misdiagnosed. Skin lesions were the most common clinical findings and skin biopsy provided histologic confirmation in most of the patients. Chronic renal failure was the only factor related to death.

Entities:  

Mesh:

Year:  2006        PMID: 17052483     DOI: 10.1016/j.jaad.2006.05.012

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Cyanotic changes of the toes.

Authors:  Dawood Al-Riyami; Rashid Al-Sukaiti; Humoud Al Duhli
Journal:  Oman Med J       Date:  2009-07

2.  Blue toes.

Authors:  Mamatha Rao; Mahmood Al-Jufaili; Prashanth Panduranga; Abdullah Amour Riyami
Journal:  Oman Med J       Date:  2012-05

Review 3.  The cholesterol emboli syndrome in atherosclerosis.

Authors:  Adriana Quinones; Muhamed Saric
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

4.  Ischemic small bowel perforation caused by cholesterol crystal embolism following transcatheter arterial chemoembolization for recurrent hepatocellular carcinoma: a case report.

Authors:  Ryoga Hamura; Koichiro Haruki; Ryota Iwase; Kenei Furukawa; Yoshihiro Shirai; Shinji Onda; Takeshi Gocho; Toru Ikegami
Journal:  Surg Case Rep       Date:  2021-02-10

5.  Cholesterol crystal embolism-related cerebral infarction: Magnetic resonance imaging and clinical characteristics.

Authors:  Yuko Kondo; Mami Kanzaki; Daisuke Ishima; Ryo Usui; Ayato Kimura; Kotaro Usui; Yasuyuki Amoh; Yasuo Takeuchi; Toshihiro Kumabe; Junya Ako; Kagami Miyaji; Kazutoshi Nishiyama; Tsugio Akutsu
Journal:  eNeurologicalSci       Date:  2021-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.